Nasdaq:US$16.21 (-0.64) | HKEX:HK$26.45 (+1.00) | AIM:£2.72 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)